Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Chun-lu Tan"'
Autor:
Xiao‐ding Shen, Xing Wang, Zhen‐jiang Zheng, Yong‐hua Chen, Chun‐lu Tan, Xu‐bao Liu, Neng‐wen Ke
Publikováno v:
Cancer Medicine, Vol 12, Iss 9, Pp 10438-10448 (2023)
Abstract Objectives Both cachexia and sarcopenia have been considered adverse predictors for prognosis in patients with pancreatic cancer; although sarcopenia and cachexia share some similarities, they are still defined as distinct nutritional condit
Externí odkaz:
https://doaj.org/article/8d27999922bd40c4aecb7176d0e459ed
Autor:
Shu-Jie Ren, Xing Wang, Neng-Wen Ke, Qing-Quan Tan, Fan Yang, Wen-Qing Yao, Chun-Lu Tan, Xu-Bao Liu
Publikováno v:
Asian Journal of Surgery, Vol 46, Iss 2, Pp 774-779 (2023)
Background: Pancreatic neuroendocrine tumors (pNETs) are heterogenous neoplasms, of which the prognosis varies widely. Purely cystic pancreatic neuroendocrine tumors (C-pNETs) are a small subset of pNETs in which data are extremely rare. This study a
Externí odkaz:
https://doaj.org/article/de47425451b6439893009202ff0d7d73
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundLiver metastases (LMs) are common in advanced pancreatic neuroendocrine tumor (PNET) patients. Currently, the benefit of primary tumor resection (PTR) in the setting of PNET patients with liver metastases is still controversial in several g
Externí odkaz:
https://doaj.org/article/dc919bc64af744569188524e6b5d9442
Autor:
Xing Wang, Jia-Jun Qiu, Chun-Lu Tan, Yong-Hua Chen, Qing-Quan Tan, Shu-Jie Ren, Fan Yang, Wen-Qing Yao, Dan Cao, Neng-Wen Ke, Xu-Bao Liu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroudTumor grade is the determinant of the biological aggressiveness of pancreatic neuroendocrine tumors (PNETs) and the best current tool to help establish individualized therapeutic strategies. A noninvasive way to accurately predict the histol
Externí odkaz:
https://doaj.org/article/7c463aed5c8645718406915abb3dbe21
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Pancreatic neuroendocrine neoplasms (p-NENs) are a group of highly heterogeneous tumors with distinct clinicopathological features and long-term prognosis. In 2017, in order to better stratify patients into prognostic groups and p
Externí odkaz:
https://doaj.org/article/12303bdfc00e4b9caef68dccf261ff5c
Autor:
Xing Wang, Yu-Qiang Shan, Qing-Quan Tan, Chun-Lu Tan, Hao Zhang, Jin-Heng Liu, Neng-Wen Ke, Yong-Hua Chen, Xu-Bao Liu
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Pancreatic ductal adenocarcinoma (PDA) is one of the most serious causes of death in the world due to its high mortality and inefficacy treatments. MEX3A was first identified in nematodes and was associated with tumor formation an
Externí odkaz:
https://doaj.org/article/295acbb01bff4ed8b671c21c46ae5879
Publikováno v:
Asian Journal of Surgery, Vol 45, Iss 5, Pp 1130-1131 (2022)
Externí odkaz:
https://doaj.org/article/e652c0b803f14c42b69942ad1010f70d
Publikováno v:
World Journal of Gastroenterology. 28:5047-5057
Solid pseudopapillary tumor (SPT) is a rare pancreatic tumor. Considering its malignant behaviors, SPT has been classified as a low-grade malignant tumor. Indeed, only 9.2% of all SPT patients are initially diagnosed as malignant with invasion or met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e017ac8fa7c3395221297943590f9fa
https://doi.org/10.3748/wjg.v28.i34.5047
https://doi.org/10.3748/wjg.v28.i34.5047
Publikováno v:
World journal of gastrointestinal oncology. 14(7)
Solid pseudopapillary neoplasms (SPNs) of the pancreas are rare, low-grade, malignant neoplasms that are mostly seen in young women in the second and third decades of life and are quite uncommon in children. Standard resection for benign and borderli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3156508f6a7a10ef51208d9fcc904703
https://pubmed.ncbi.nlm.nih.gov/36051095
https://pubmed.ncbi.nlm.nih.gov/36051095
Publikováno v:
Frontiers in oncology. 12
BackgroundLiver metastases (LMs) are common in advanced pancreatic neuroendocrine tumor (PNET) patients. Currently, the benefit of primary tumor resection (PTR) in the setting of PNET patients with liver metastases is still controversial in several g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8800ac699ed1c0d19ddec6063633b53c
https://pubmed.ncbi.nlm.nih.gov/35350567
https://pubmed.ncbi.nlm.nih.gov/35350567